Journal
CANCER RESEARCH
Volume 73, Issue 1, Pages 417-427Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-12-1881
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research (CIHR) [RMF-92090]
- Canadian Cancer Society Research Institute (CCSRI) [018047]
- Ontario Institute for Cancer Research (OICR) [STP-PRAR-HSK]
- Jessica's Footprint
- Ontario Genomics institute
- Genome Canada
Ask authors/readers for more resources
Glioblastoma growth is driven by cancer cells that have stem cell properties, but molecular determinants of their tumorigenic behavior are poorly defined. In cancer, altered activity of the epigenetic modifiers Polycomb and Trithorax complexes may contribute to the neoplastic phenotype. Here, we provide the first mechanistic insights into the role of the Trithorax protein mixed lineage leukemia (MLL) in maintaining cancer stem cell characteristics in human glioblastoma. We found that MLL directly activates the Homeobox gene HOXA10. In turn, HOXA10 activates a downstream Homeobox network and other genes previously characterized for their role in tumorigenesis. The MLL-Homeobox axis we identified significantly contributes to the tumorigenic potential of glioblastoma stem cells. Our studies suggest a role for MLL in contributing to the epigenetic heterogeneity between tumor-initiating and non-tumor-initiating cells in glioblastoma. Cancer Res; 73(1); 417-27. (C)2012 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available